Advertisement
U.S. markets open in 3 hours 52 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.8300+0.0300 (+1.67%)
At close: 04:00PM EDT
1.8500 +0.02 (+1.09%)
Pre-Market: 05:23AM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
Operating Expense
30,496
27,691
20,521
14,607
Operating Income
-30,496
-27,691
-20,521
-14,607
Net Non Operating Interest Income Expense
3,777
877
6
-938.794
Other Income Expense
-3,112
-146
-91
-3,221
Pretax Income
-29,831
-26,960
-20,606
-17,828
Tax Provision
0
0
0
0
Net Income Common Stockholders
-29,831
-26,960
-20,606
-22,331
Diluted NI Available to Com Stockholders
-29,831
-26,960
-20,606
-22,331
Basic EPS
-0.24
-0.21
-0.18
-1.97
Diluted EPS
-0.24
-0.21
-0.18
-1.97
Basic Average Shares
126,414
126,624
116,950
11,309
Diluted Average Shares
126,414
126,624
116,950
11,309
Total Operating Income as Reported
-30,496
-27,691
-20,521
-14,607
Total Expenses
30,496
27,691
20,521
14,607
Net Income from Continuing & Discontinued Operation
-29,831
-26,960
-20,606
-17,828
Normalized Income
-26,841
-26,960
-20,606
-14,556
Interest Income
3,777
877
6
-
Net Interest Income
3,777
877
6
-938.794
EBIT
-30,496
-27,691
-20,521
-14,607
EBITDA
-30,485
-27,683
-20,498
-14,560
Reconciled Depreciation
11
8
23
47
Net Income from Continuing Operation Net Minority Interest
-29,831
-26,960
-20,606
-17,828
Total Unusual Items Excluding Goodwill
-2,990
-
-
-3,272
Total Unusual Items
-2,990
-
-
-3,272
Normalized EBITDA
-27,495
-27,683
-20,498
-11,288
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0